Postmenopausal estrogen-containing hormone therapy and the risk of breast cancer

Obstetrics and Gynecology

Volumn 113, Issue 1, 2009, Pages 74-80

  Jick, Susan S ^a   Hagberg, Katrina W ^a   Kaye, James A ^a   Jick, Hershel ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; GESTAGEN; METHYLTESTOSTERONE; TESTOSTERONE;

ADULT; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MONOTHERAPY; POSTMENOPAUSE; PRIORITY JOURNAL; UNITED STATES; AGED; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; ESTROGEN THERAPY; MIDDLE AGED; RISK FACTOR;

AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; ESTROGEN REPLACEMENT THERAPY; ESTROGENS, CONJUGATED (USP); ESTROGENS, ESTERIFIED (USP); FEMALE; HUMANS; METHYLTESTOSTERONE; MIDDLE AGED; PROGESTINS; RISK FACTORS; TESTOSTERONE;

EID: 60749131430     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e31818fdde4     Document Type: Article

References (13)

1. Colditz GA, Hankinson SE, Hunter DJ, Willett WC, Manson JE, Stampfer MJ, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 1995;332:1589-93.
2. Olsson HL, Ingvar C, Bladström A. Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden. Cancer 2003;97:1387-92.
3. Li CI, Malone KE, Porter PL, Weiss NS, Tang MC, Cushing-Haugen KL, et al. Relationship between long durations and different regimens of hormone therapy and risk of breast cancer. JAMA 2003;289:3254-63.
4. Beral V; Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women study [published erratum appears in Lancet 2003;362:1160]. Lancet 2003;362:419-27.
5. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33.
6. Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004;291: 1701-12.
7. Anderson GL, Chlebowksi RT, Rossouw JE, Rodabough RJ, McTiernan A, Margolis KL, et al. Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin. Maturitas 2006;55:103-15.
8. Campbell S, Whitehead M. Oestrogen therapy and the meno-pausal syndrome. Clin Obstet Gynaecol 1977;4:31-47.
9. Davis SR. The therapeutic use of androgens in women. J Steroid Biochem Mol Biol 1999;69:177-84.
10. Davis SR. Androgen treatment in women. Med J Aust 1999; 170:545-9.
11. Davis SR. The use of testosterone after menopause. J Br Menopause Soc 2004;10:65-9.
12. Tamimi RM, Hankinson SE, Chen WY, Rosner B, Colditz GA. Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women. Arch Intern Med 2006;166: 1483-9.
13. Ito K. Hormone replacement therapy and cancers: the biological roles of estrogen and progestin in tumorigenesis are different between the endometrium and breast. Tohoku J Exp Med 2007;212:1-12.